Publications

2024

160. Linn C., O’Malley A., Khatri K., Wright E.M., Sebagh D., Grbić M., Kowal K., Chruszcz M. (2024) “Microscopic Menaces: The Impact of Mites on Human Health.” International Journal of Molecular Sciences 25, 3675. DOI: 10.3390/ijms25073675

159. Pomés A., Smith S.A., Chruszcz M., Mueller G.A., Brackett N.F., Chapman M.D. (2024) “Precision engineering for localization, validation, and modification of allergenic epitopes.” Journal of Allergy and Clinical Immunology 153, 560-571. DOI: 10.1016/j.jaci.2023.12.017

Cryo-EM structure of Bet v 1 in complex with 3 different Fab fragments of antibodies REGN5713, REGN5714, and REGN5715 (PDB code: 7MXL).

158. Ruffatto K., da Silva C.R., Berté, A.L.W., Grabin S., de Souza E.V., Arriaza R.H., Chruszcz M., Johann L., Sperotto R.A., Timmers L.F.S.M. (2024) “Workflow of structural genomics and bioinformatic approaches to identify natural compounds able to inhibit species-specific proteins in Tetranychus urticae.” Journal of Pest Science 97, 667-683. DOI: 10.1007/s10340-023-01669-7

Sructure of T. urticae dioxygenase that is a potential target for development of acaricides

157. Carey S.M., Kearns S.P., Millington M.E., Buechner G.S., Alvarez B.E. Jr., Daneshian L., Abiskaroon B., Chruszcz M., D’Antonio E.L. (2024) “At the outer part of the active site in Trypanosoma cruzi glucokinase: The role of phenylalanine 337.” Biochimie 218, 8-19. DOI: 10.1016/j.biochi.2023.09.014

Crystal structure of Trypanosoma cruzi glucokinase (F337A mutant) in open conformation. Mutated residues are marked in yellow and shown in sphere representation.